These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 16250906)

  • 1. The ubiquitin-proteasome system and cancer.
    Devoy A; Soane T; Welchman R; Mayer RJ
    Essays Biochem; 2005; 41():187-203. PubMed ID: 16250906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell cycle checkpoint control mechanisms that can be disrupted in cancer.
    Dash BC; El-Deiry WS
    Methods Mol Biol; 2004; 280():99-161. PubMed ID: 15187251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubiquitination and deubiquitination: Implications on cancer therapy.
    Dagar G; Kumar R; Yadav KK; Singh M; Pandita TK
    Biochim Biophys Acta Gene Regul Mech; 2023 Dec; 1866(4):194979. PubMed ID: 37633647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the ubiquitin-proteasome system to activate wild-type p53 for cancer therapy.
    Allende-Vega N; Saville MK
    Semin Cancer Biol; 2010 Feb; 20(1):29-39. PubMed ID: 19897040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulation of ubiquitin ligases in cancer.
    Qi J; Ronai ZA
    Drug Resist Updat; 2015 Nov; 23():1-11. PubMed ID: 26690337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Involvement of Ubiquitination Machinery in Cell Cycle Regulation and Cancer Progression.
    Zou T; Lin Z
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the ubiquitin proteasome system in hematologic malignancies.
    Sahasrabuddhe AA; Elenitoba-Johnson KS
    Immunol Rev; 2015 Jan; 263(1):224-39. PubMed ID: 25510280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gankyrin, the 26 S proteasome, the cell cycle and cancer.
    Mayer RJ; Fujita J
    Biochem Soc Trans; 2006 Nov; 34(Pt 5):746-8. PubMed ID: 17052188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nuclear ubiquitin-proteasome system: visualization of proteasomes, protein aggregates, and proteolysis in the cell nucleus.
    von Mikecz A; Chen M; Rockel T; Scharf A
    Methods Mol Biol; 2008; 463():191-202. PubMed ID: 18951170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the ubiquitin-proteasome system in brain ischemia: friend or foe?
    Caldeira MV; Salazar IL; Curcio M; Canzoniero LM; Duarte CB
    Prog Neurobiol; 2014 Jan; 112():50-69. PubMed ID: 24157661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATM engages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage.
    Dornan D; Shimizu H; Mah A; Dudhela T; Eby M; O'rourke K; Seshagiri S; Dixit VM
    Science; 2006 Aug; 313(5790):1122-6. PubMed ID: 16931761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The vital link between the ubiquitin-proteasome pathway and DNA repair: impact on cancer therapy.
    Motegi A; Murakawa Y; Takeda S
    Cancer Lett; 2009 Sep; 283(1):1-9. PubMed ID: 19201084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of apoptosis by E3 ubiquitin ligases in ubiquitin proteasome system.
    Sharma A; Trivedi AK
    Cell Biol Int; 2020 Mar; 44(3):721-734. PubMed ID: 31814188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NRF3-POMP-20S Proteasome Assembly Axis Promotes Cancer Development via Ubiquitin-Independent Proteolysis of p53 and Retinoblastoma Protein.
    Waku T; Nakamura N; Koji M; Watanabe H; Katoh H; Tatsumi C; Tamura N; Hatanaka A; Hirose S; Katayama H; Tani M; Kubo Y; Hamazaki J; Hamakubo T; Watanabe A; Murata S; Kobayashi A
    Mol Cell Biol; 2020 Apr; 40(10):. PubMed ID: 32123008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the ubiquitin proteasome system in haematological malignancies.
    Crawford LJ; Irvine AE
    Blood Rev; 2013 Nov; 27(6):297-304. PubMed ID: 24183816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the ubiquitin proteasome system in lymphoma.
    Suh KS; Tanaka T; Sarojini S; Nightingale G; Gharbaran R; Pecora A; Goy A
    Crit Rev Oncol Hematol; 2013 Sep; 87(3):306-22. PubMed ID: 23541070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitin-proteasome pathway and prostate cancer.
    Chen FZ; Zhao XK
    Onkologie; 2013; 36(10):592-6. PubMed ID: 24107915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ubiquitin-proteasome pathway and its role in cancer.
    Mani A; Gelmann EP
    J Clin Oncol; 2005 Jul; 23(21):4776-89. PubMed ID: 16034054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Ubiquitin Proteasome Pathway (UPP) in the regulation of cell cycle control and DNA damage repair and its implication in tumorigenesis.
    Tu Y; Chen C; Pan J; Xu J; Zhou ZG; Wang CY
    Int J Clin Exp Pathol; 2012; 5(8):726-38. PubMed ID: 23071855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant ubiquitin-mediated proteolysis of cell cycle regulatory proteins and oncogenesis.
    Bashir T; Pagano M
    Adv Cancer Res; 2003; 88():101-44. PubMed ID: 12665054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.